AwesomeCapital
Search This Blog
Monday, June 17, 2019
Ultragenyx (RARE) Upcoming Data Could Move Shares – Morgan Stanley
Analyst Jeffrey Hung reiterated an Overweight rating and $83.00 price target
https://www.streetinsider.com/Analyst+Comments/Ultragenyx+Pharma+%28RARE%29+Upcoming+Data+Could+Move+Shares+-+Morgan+Stanley/15617324.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.